Natco Pharma’s shares dropped 19% on February 13 after the release of its third-quarter results for fiscal 2024-25, which ended in December 2024.

Meanwhile, the value of five pharmaceutical companies fell in 2017 as Merck & Co, Celgene, GlaxoSmithKline (GSK), Allergan and Shire all saw their market capitalisation decline.

(While some make distinctions between biotech and biopharma, biotech in this context refers to companies that are not considered large pharmaceutical companies, irrespective of their modality.) ...

Anebulo Pharmaceuticals , Inc. (NASDAQ:ANEB), a Delaware-based pharmaceutical company with a market capitalization of $37.6 million, announced Monday that its Board of Directors has scheduled the ...

The Union Health Ministry has conditionally extended the deadline for implementing the revised Schedule M, a set of good manufacturing practices for small and medium pharmaceutical companies, till ...

Shares of IPCA Laboratories have yielded a return of 8 per cent in the last six months and nearly 30 per cent in the last one ...

The pharma companies made drugs that could help patients and spent lots of time telling doctors which drugs to give to who. Then payers came along and started scrutinising how much was being spent ...